ANN ARBOR, Mich., June 01, 2022 (GLOBE NEWSWIRE) — Esperion (NASDAQ: ESPR) today announced the appointment of J. Martin Carroll as Chairperson of Esperion’s Board of Directors. Mr. Carroll will serve as a Class I director with a term expiring at the 2023 annual meeting of stockholders. “On behalf of […]
Financial
TRIDENTCARE EXPANDS ITS NATIONAL PRESENCE IN KEY MARKETS WITH THE ACQUISITION OF MIDWEST X-RAY
SPARKS, Md., June 01, 2022 (GLOBE NEWSWIRE) — TridentCare, a national leader of portable diagnostic services, announces significant growth in Kentucky, Illinois, and Indiana with the acquisition of Midwest X-Ray. “On behalf of the entire organization, we are thrilled to welcome the dedicated Midwest team members and loyal customers to […]
AtriCure Announces the Appointment of Deborah Yount as Chief Human Resources Officer
MASON, Ohio–(BUSINESS WIRE)–AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, announced the appointment of Deborah Yount as Chief Human Resources Officer, effective today. Ms. Yount will have responsibility for global Human Resources activities. “We […]
Fivos and Cedaron Partner to Further Vascular Care and Collaboration Through Participation in Society for Vascular Surgery Vascular Quality Initiative
ATLANTA–(BUSINESS WIRE)–Fivos announces a strategic partnership with Cedaron Medical to expand participation in the Society for Vascular Surgery® Vascular Quality Initiative® (SVS VQI) by combining Fivos’ robust registry platform services with Cedaron’s data collection and management expertise. Fivos provides national registry services for SVS VQI, which collects extensive data on vascular procedures, including devices […]
Occlutech Q1 2022 – Strong Revenue Increase and Important Milestones Achieved in the Strategic US Market
SCHAFFHAUSEN, SWITZERLAND / ACCESSWIRE / May 31, 2022 / Occlutech Holding AG Occlutech Holding AG (Occlutech) is a leading specialist provider of minimally invasive structural heart implants. The company sells and markets its products in around 85 countries and the global addressable market for congenital and structural heart devices provides a […]
Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
MONTREAL and CHARLOTTE, N.C., May 27, 2022 /PRNewswire/ — Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced that Milestone’s Compensation Committee granted three new employees incentive stock options to purchase an aggregate of 92,000 common shares, at a per share exercise price of $5.48, […]
BIOMERICS ANNOUNCES EXPANSION INTO IRELAND
Expands High-Performance Balloon Design & Development Capabilities in Galway SALT LAKE CITY, May 31, 2022 /PRNewswire/ — Biomerics, the leading vertically integrated medical device contract manufacturer serving the interventional device market, has today announced the opening of a 2,000 sq. ft. Balloons & Balloon Catheters Centre of Excellence in Galway and the […]
Silk Road Medical Extends Cash Runway by Securing up to $250 Million in Debt Financing
SUNNYVALE, Calif., May 31, 2022 (GLOBE NEWSWIRE) — Silk Road Medical, Inc. (Company) (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced that it has entered into a new five-year loan arrangement with Oxford Finance LLC (Oxford) comprising up to a $200 […]
Occlutech Announces Changes to the Executive Management Team
SCHAFFHAUSEN, SWITZERLAND / ACCESSWIRE / May 31, 2022 / Occlutech Holding AG Occlutech Holding AG (Occlutech), a leading specialist provider in minimally invasive structural heart implants has changed its Executive Management Team with three new members. Thomas Okke Frahm has been recruited as VP IT while Sakarias Lindell and Luis Martin-Parras, […]
Mana Capital Acquisition Corp. and Cardio Diagnostics, Inc. Announce Definitive Business Combination Agreement to Create Publicly Listed Company Set to Transform Cardiovascular Disease Through Epigenetics
Cardio Diagnostics, Inc. has pioneered a proprietary artificial intelligence-driven Integrated Genetic-Epigenetic Engine™ that enables improved diagnosis and prevention of cardiovascular disease The Company’s flagship product, Epi+Gen CHD™, is a highly sensitive and accessible clinical test that assesses the 3-year risk for coronary heart disease, which is the most common type […]



